Next Article in Journal
Chemical Constituents and Biological Activities of Bruguiera Genus and Its Endophytes: A Review
Next Article in Special Issue
Marine Prostanoids with Cytotoxic Activity from Octocoral Clavularia spp.
Previous Article in Journal
Protein Hydrolysis as a Way to Valorise Squid-Processing Byproducts: Obtaining and Identification of ACE, DPP-IV and PEP Inhibitory Peptides
Previous Article in Special Issue
Lemneolemnanes A–D, Four Uncommon Sesquiterpenoids from the Soft Coral Lemnalia sp.
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

New Diterpenes and Diterpene Glycosides with Antibacterial Activity from Soft Coral Lemnalia bournei

1
Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Research Center, Ningbo University, Ningbo 315211, China
2
Department of Marine Pharmacy, College of Food Science and Engineering, Ningbo University, Ningbo 315800, China
3
Institute of Drug Discovery Technology, Ningbo University, Ningbo 315211, China
4
Ningbo Institute of Marine Medicine, Peking University, Ningbo 315800, China
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Mar. Drugs 2024, 22(4), 157; https://doi.org/10.3390/md22040157
Submission received: 13 March 2024 / Revised: 28 March 2024 / Accepted: 28 March 2024 / Published: 29 March 2024
(This article belongs to the Special Issue Bioactive Compounds from Soft Corals and Their Derived Microorganisms)

Abstract

:
Five new biflorane-type diterpenoids, biofloranates E–I (15), and two new bicyclic diterpene glycosides, lemnaboursides H–I (67), along with the known lemnabourside, were isolated from the South China Sea soft coral Lemnalia bournei. Their chemical structures and stereochemistry were determined based on extensive spectroscopic methods, including time-dependent density functional theory (TDDFT) ECD calculations, as well as a comparison of them with the reported values. The antibacterial activities of the isolated compounds were evaluated against five pathogenic bacteria, and all of these diterpenes and diterpene glycosides showed antibacterial activities against Staphylococcus aureus and Bacillus subtilis, with MICs ranging from 4 to 64 µg/mL. In addition, these compounds did not exhibit noticeable cytotoxicities on A549, Hela, and HepG2 cancer cell lines, at 20 μM.

1. Introduction

Marine organisms constitute a treasure trove of biologically active natural products. Soft corals are particularly noteworthy for their rich array of secondary metabolites. The genus Lemnalia within soft corals (Coelenterata, Octocorallia, Alcyonacea) is renowned for its diverse terpenoid compounds [1,2,3,4,5], including sesquiterpenes, diterpenoids, diterpene glycosides, and steroids, which exhibit significant biological activities. Sesquiterpenoids, in particular, emerged as the predominant and characteristic metabolites of the Lemnalia genus due to their plentiful occurrence and structural diversity [1,6,7,8]. In contrast, biflorane-based diterpenoids are less prevalent, forming minor constituents in Lemnalia soft coral [2,5].
Significantly, the secondary metabolites derived from the Lemnalia genus frequently feature innovative carbon atom linkages and substituent configurations. Prior research indicates that Lemnalia-derived diterpenoids exhibit a variety of ring structures, including biflorane, 5,3,6-tricyclic, 5,7,3-tricyclic, and 10-membered carbocyclic frameworks, which are biogenetically interconnected [2,5]. Geranylgeranyl pyrophosphate (GGPP, C20) is considered the common biosynthetic precursor for these diterpenoids. Specifically, lemnaboursides from Lemnalia bournei are diterpene glycosides, featuring D-glucose linked to a diterpene aldehyde via an acetal bond, acetylated or modified by the lemnal-1(10)-ene-7,12-diol group on the sugar moiety, or as derivatives with opened ring D [9,10,11,12]. Diterpenoids and diterpene glycosides demonstrate a wide range of biological activities, including antibacterial, antiviral, and anti-inflammatory effects [2].
As part of our ongoing program to search for biologically active compounds from marine organisms, we collected the soft coral Lemnalia bournei off the coast of Xisha Island in April 2021. Chemical investigation of the acetone extract led to the isolation and identification of five new biflorane-type diterpenoids, named biofloranates E–H (15), and two new bicyclic diterpene glycosides, named lemnaboursides H–I (67) (Figure 1). This paper describes the isolation, structural elucidation, and antibacterial activity evaluation of these isolates.

2. Results

Biofloranate E (1) was isolated as a colorless oil. Its molecular formula was determined to be C20H36O2 using HRESIMS (m/z 291.2669 [M − H2O + H]+ (calcd for C20H35O2, 291.2682), requiring three degrees of unsaturation. The 1H and 13CNMR spectra (Table 1) showed 20 resonances attributable to two sp2 olefinic carbons (one CH and one quaternary) and eighteen sp3 carbons (four CH3, eight CH2, five CH, and one C), including two oxygenated ones, accounting for one of the three degrees of unsaturation suggested by the molecular formula (Supplementary Materials). The remaining two degrees of unsaturation indicated that compound 1 had to be bicyclic. The bicyclic biflorane framework was established through comprehensive 2D NMR analysis [5]. The 1H-1H COSY spectrum delineated the proton connectivities between H2-2/H2-1/H-10/H-5/H-6/H2-7/H2-8, H-6/H-11/H2-12/H2-13/H2-14/H-15/H2-16, H-11/H3-18, and H-15/H3-17. These data together with the key HMBC correlations (Figure 2), such as H2-1, H2-2, H3-19/C-3 and H2-1, H2-7, H2-8, H3-20/C-9, facilitated the elucidation of the planar structure of 1.
The relative configuration of 1 was ultimately determined using 1D NOE spectroscopy. NOEs observed between H-5 and H3-18, and H-10 and H-5, indicated that H-5, H-10, and the 11-Me group are on the same side of the molecule (Figure 3). The lack of NOE interactions between H-5/H-11, H-6/H3-18, and H-10/H3-20 suggested that H-6, H-11, and the 9-Me group are oriented on the opposite face. The absolute configurations of 1 were deduced using TDDFT/ECD calculations. The Boltzmann-averaged ECD spectrum for the (5R, 6S, 9S, 10S, 11R) configuration of 1 closely matched the experimental spectrum, as anticipated (Figure 4a). The ECD spectroscopic data, in conjunction with the biogenetic analysis, confirmed the absolute configuration of compound 1 as 5R, 6S, 9S, 10S, 11R. However, the configuration at C-15 remained elusive.
Biofloranate F (2) was also obtained as a colorless oil. The HRESIMS analysis indicated a molecular formula of C20H32O2 for 2, with an ion peak at m/z 287.2371 [M − H2O + H]+ (calcd for C20H31O, 287.2375), suggesting five degrees of unsaturation. The molecular formula of 2, when compared to compound 1, indicated a deficiency of four hydrogens, which is consistent with an additional double bond (δC/δH 155.2/6.46 and δC139.3) and an aldehyde group (δC/δH 195.5/9.37). The 1H-1H COSY cross-peak between H2-13/H-14, along with the HMBC correlation of H-14/C-12/C-13/C-15/C-16/C-17 (Figure 2), confirmed the presence of an additional double bond between C-14 and C-15 in 2. The location of the aldehyde group was determined through the HMBC correlations from H-16 to C-14, C-15 and C-17, from H3-17 to C-16, and from H-14 to C-16. Consequently, the planar structure of 2 was established. The distinct NOE correlations between H-14 and H-16 suggested the E geometry for the trisubstituted double bond Δ14(15). The relative stereochemistry of 2 was also assigned by 1D NOE spectra analysis between H3-18/H-5, H3-20/H-5, and H3-20/H-10, and no NOE could be detected between H3-18 and H-6. Based on these findings, the relative configuration of 2 was determined to be 5R*, 6S*, 9R*, 10S*, 11R*.
Biofloranate G (3) was also obtained as a colorless oil. The molecular formula of C21H36O3 and four degrees of unsaturation were inferred from its HRESIMS at m/z 319.2637 [M − H2O + H]+ (calcd. 319.2637). Examination of the 1H and 13C NMR spectrum revealed that the difference between compounds 2 and 1 was due to the presence of an ester carbonyl group (δC/δH 177.6 and 51.6/3.67) at C-15 in 2, replacing the oxygenated methylene group found in 1. This was corroborated by the corresponding HMBC correlations (Figure 2). The relative stereochemistry of 3 was also determined through key NOE interactions of H-5/H3-20, H-5/H-10 and H-5/H3-18, and no NOE was detected between H-5 and H-6. Considering biogenetic information, the absolute configuration of 3 was established. However, the stereochemistry at C-15 remained unresolved.
Biofloranate H (4), a colorless oil, was found to have a molecular formula of C21H34O3, as determined by HRESIMS at m/z 317.2496 [M − H2O + H]+ (calcd. 317.2481), indicating five degrees of unsaturation. The 1D NMR data of 4 closely resembled those of 3, except for an additional double bond characterized by chemical shifts δC/δH of 142.8/6.76 and 127.5. The 1H-1H COSY correlation of H2-13/H-14, and HMBC correlations of H-14/C-12/C-13/C-15/C-16/C-17 (Figure 2), confirmed the presence of an additional double bond between C-14 and C-15 in 4. The planar structure of 4 was determined. Additionally, compound 5 was identified to have the same molecular formula as 4, based on HRESIMS analysis. Comparison of the 1D and 2D NMR spectral data of 5 with 4 revealed identical planar structures. The E geometry of the 14,16-double bonds in compounds 4 and 5 was inferred from 1D NOE enhancements observed for the H-14/16-OMe moiety. The relative configurations of the two enantiomers were also determined using 1D NOE spectra. For compound 4, the NOEs of H3-18/H-5, H3-18/H-6, H-5/H3-20, and H-10/H3-20 indicated that these protons are on the same face of the molecule. Consequently, the relative configuration of 4 was determined to be 5R*, 6R*, 9R*, 10S*, 11R*. Similarly, for compound 5, the NOEs of H3-18/H-5, H-5/H3-20, and H-10/H3-20 positioned these protons on the same face, while the absence of an NOE correlation between H-6 and H3-18 suggested a different relative configuration of 5R*, 6S*, 9R*, 10S*, 11R*.
The absolute configurations of compounds 2, 3, and 5 were determined by comparing their experimental CD spectroscopic data with that of compound 1. As depicted in Figure 4a, the CD spectrum of compounds 13 and 5 exhibited a broad positive Cotton effect at 200 nm. For compound 4, the experimental ECD spectrum was compared with the calculated spectrum for the (5R,6S,9R,10S,11R) configuration (Figure 4b), confirming the absolute configuration of 4.
Lemnabourside H (6) was obtained as an amorphous solid. Its molecular formula was determined to be C30H46O8 by HRESIMS (m/z 557.3082 [M + Na]+ (calcd for C30H46O8, 557.3114), requiring eight degrees of unsaturation. The spectral data of 6 closely resembled those of diterpene glycosides isolated from Lemnalia bournei [9,10] (Table 2), except for two acetyl groups substituted on distinct hydroxyl groups of the sugar moiety. The D-glucose was confirmed to be in boat form, as reported in [12]. The position of two acetyl groups at 2′- and 3′-OH groups was established through HMBC correlations from H-2′ to 2′-OAc (δC 170.4), and from H-3′ to 3′-OAc (δC 171.5). Acid hydrolysis of 6, performed according to a previously reported method [12], yielded D-glucose and diterpene aldehyde. The relative stereochemistry of the diterpene unit of 6 was inferred from 1D NOE experiments (Figure 3) and biogenetic consideration.
Lemnabourside I (7) was isolated as a yellow solid. It exhibited an HRESIMS ion peak at m/z 643.3478 [M + Na]+, consistent with a molecular formula of C34H52O10. NMR analysis (Table 2) indicated that 7 is a ring D opened diterpene glycoside, similar to lemnaboursides F and G, with all hydroxyl groups of the glucose acetylated. The 1H-1H COSY, HSQC, HMBC, and 1D NOE experiments facilitated the complete structural assignment of 7 (Figure 2 and Figure 3). Acid hydrolysis of 7 also yielded D-glucose and a diterpene aldehyde. The coupling constant of the anomeric proton (1H, d, J = 8 Hz) suggested that the glucose moiety of 7 was in chair form [12]. The absolute configurations of 6 and 7 were deduced by comparison of the experimental CD spectroscopic data with the known compound 8, which showed a negative Cotton effect at 197 nm (Figure 4c).
The antibacterial activities of compounds 18 were assessed against five pathogenic bacteria: Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa, Streptococcus pneumoniae, and Escherichia coli. As shown in Table 3, all of these diterpenes and diterpene glycosides displayed antibacterial activities against Staphylococcus aureus and Bacillus subtilis, with MICs ranging from 4 to 64 µg/mL. None of the compounds exhibited an antibacterial effect against Streptococcus pneumoniae. Furthermore, the cytotoxicity of the isolated compounds was evaluated in vitro against A549, HeLa, and HepG2 at 20 μM. The results showed that these compounds were inactive against tested cell lines.

3. Materials and Methods

3.1. General Chemical Experimental Procedures

A ThermoFisher Evolution 201/220 spectrophotometer (Thermo Scientific, Waltham, MA, USA) was used for UV spectroscopy measurements. Optical rotations were measured using a Jasco P-1010 Polarimeter (JASCO, Tokyo, Japan) with sodium light (589 nm). NMR spectra were recorded on a Bruker AVANCE NEO 600 spectrometer (BrukerBiospin AG, Fällanden, Germany). 1H chemical shifts were referenced to the residual CDCl3 (7.26 ppm), and 13C chemical shifts were referenced to the CDCl3 (77.2 ppm) solvent peaks. High-resolution electrospray ionization mass spectra (HRESIMS) were performed on an ultra-high-performance liquid chromatograph (UPLC) and TIMS-QTOF high-resolution mass spectrometry (Waters, Milford, MA, USA). The purification was performed by reversed-phase high-performance liquid chromatography using a Shimadzu LC-20AT system (Shimadzu Corporation, Tokyo, Japan). The solvents used for HPLC were all Fisher HPLC grade. A Cosmosil C18-MS-II column (250 mm × 20.0 mm, id, 5 μm, Cosmosil, Nakalai Tesque Co., Ltd., Kyoto, Japan) was used for the preparative HPLC separation. Column chromatography was performed using silica gel (300–400 mesh, Qingdao Ocean Chemical Co. Ltd., Qingdao, China) and C18 reversed-phase silica gel (75 µm, Nakalai Tesque Co., Ltd., Kyoto, Japan).

3.2. Animal Material

Soft coral Lemnalia bournei was sampled off the coast of Xisha Islands, South China Sea, 7 m underwater, and frozen immediately after collection. The specimens (XSSC202103) were deposited at the Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Research Center, Health Science Center, Ningbo University, China.

3.3. Extraction and Isolation

The frozen soft coral Lemnalia bournei (dry weight: 198.0 g) was freeze-dried and cut into pieces. Then, it was extracted with CH2Cl2 and MeOH 5 times. The combined extract was evaporated and concentrated to obtain a crude residue, which was then partitioned between Et2O and H2O. The Et2O solution was concentrated under reduced pressure to give a residue (24.0 g). The residue was eluted with petroleum ether/EtOAc (100:0~1:1, v:v) on a gradient silica gel column chromatography, and five fractions (Fr.1~Fr.5) were obtained. Fr.1 (693.9 mg) was eluted with MeOH/H2O (50:50 to 100:0, v/v) on reversed-phase column chromatography to obtain four subfractions (Fr.1.1-Fr.1.4). Purification of Fr.1.3 (25.8 mg) by semi-preparative HPLC (MeCN/H2O, 46:54, 2 mL/min) gave compounds 1 (3.5 mg) and 2 (3.9 mg). Separation of Fr.2 (647.9 mg) on a reversed-phase column with MeOH/H2O (50:50~100:0, v/v) afforded seven subfractions (Fr.2.1~Fr.2.7). Fr.2.5 (13.5 mg) was purified using semipreparative reversed-phase HPLC (MeCN/H2O, 72: 28, 2 mL/min) to afford compounds 3 (2.3 mg) and 4 (2.7 mg). Fr.3 (647.9 mg) was eluted with MeOH/H2O (40:60~80:20, v/v) on an ODS column to give seven subfractions (Fr.3.1~Fr.3.7). Fr.3.5 (29.1 mg) was purified using semi-preparative reversed-phase HPLC (MeCN/H2O, 72:28, 2 mL/min) to give compound 5 (3.1 mg). Fr.4 (881.5 mg) was separated on an ODS column with MeOH/H2O (58:42~100:0, v/v) to give six subfractions (Fr.4.1-Fr.4.6). Fr.4.2 (19.3 mg) was purified using HPLC (MeCN/H2O, 92:8, 2 mL/min) to obtain compound 6 (6.3 mg). Fr.4.3 (15.7 mg) was purified using semi-preparative HPLC (MeCN/H2O, 90:10, 2 mL/min) to give compound 7 (4.1 mg). Fr.5 was separated on reversed-phase MPLC using the mobile phase of MeOH-H2O (60:40~80:20, v/v) to obtain compound 8 (125.0 mg).
Biofloranate E (1): colorless oil; {[α ] D 25 + 23.3 (c 0.10, MeOH)}; UV (MeOH) λmax (log ε) 197 (0.84) nm; 1H and 13C NMR data, Table 1; HRESIMS m/z 291.2669 [M − H2O + H]+ (calcd for C20H35O, 291.2682).
Biofloranate F (2): colorless oil; {[α ] D 25 + 21.8 (c 0.10, MeOH)}; UV (MeOH) λmax (log ε) 198 (1.56) nm; 229 (0.54) nm; 1H and 13C NMR data, Table 1; HRESIMS m/z 287.2371 [M − H2O + H]+ (calcd for C20H31O, 287.2375).
Biofloranate G (3): colorless oil; {[α ] D 25 + 26.7 (c 0.10, MeOH)}; UV (MeOH) λmax (log ε) 204(0.89) nm; 1H and 13C NMR data, Table 1; HRESIMS m/z 319.2636 [M − H2O + H]+ (calcd for C21H35O2, 319.2637).
Biofloranate H (4): colorless oil; {[α ] D 25 + 19.3 (c 0.10, MeOH)}; UV (MeOH) λmax (log ε) 209 (0.99) nm; 1H and 13C NMR data, Table 1; HRESIMS m/z 317.2496 [M − H2O + H]+ (calcd for C21H33O2, 317.2481).
Biofloranate I (5): colorless oil; {[α ] D 25 + 19.3 (c 0.10, MeOH)}; UV (MeOH) λmax (log ε) 217 (1.05) nm; 1H and 13C NMR data, Table 1; HRESIMS m/z 317.2472 [M − H2O]+ (calcd for C21H33O2, 317.2463).
Lemnabourside H (6): amorphous solid; {[α ] D 25 + 21.66 (c0.10, MeOH)}; UV (MeOH) λmax (log ε)203(0.97) nm; 1H and 13C NMR data, Table 2; HRESIMS m/z 557.3082 [M + Na]+ (calcd for C30H46O8Na, 557.3091).
Lemnabourside I (7): yellow solid; {[α ] D 25 + 38.2 (c 0.10, MeOH)}; UV (MeOH) λmax (log ε) 199 (1.44) nm. 1H and 13C NMRdata, Table 2; HRESIMS m/z 643.3427 [M + Na]+ (calcd for C34H52O10Na, 643.3458).

3.4. DFT-ECD Calculation

Theoretical ECD spectra of compounds 1 and 4 were calculated using the Gaussian 16 program package. Conformational analysis and density functional theory (DFT) calculations were used to generate and optimize conformations at the B3LYP/6-311G (2d,p) level of theory, following the method reported in [13].

3.5. Antibacterial Assays

All the isolated compounds were tested for antibacterial activities by following the literature [14]. Five bacterial strains of Staphylococcus aureus [CMCC (B) 26003], Bacillus subtilis [CMCC (B) 63501], Vibrio harveyi 1708B04 (accession number: MZ333451), Streptococcus pneumoniae [CMCC (B) 31001], and Escherichia coli [CMCC (B) 44102] were selected, and penicillin G was chosen as a positive control. Compounds 18 were dissolved in DMSO and tested at concentrations of 128, 64, 32, 16, 8, 4, and 2 µg/mL. Briefly, the bacteria were grown in MH medium for 24 h at 28 °C with agitation (180 rpm) and then diluted with sterile MH medium to match 0.5 McFarland standard. One hundred microliters of each bacterial supernatant and 100 μL of MH medium with 0.002% 2,3,5-triphenyltetrazolium chloride, together with test or control materials, were incubated. Then, the inhibition data were recorded optically.

3.6. Cytotoxic Activity Assays

A549, HeLa, and HepG2 cells were cultured in DMEM (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% FBS (Gibco; Thermo Fisher Scientific, Inc.). A549, HeLa, and HepG2 cells were obtained from the Chinese Academy of Science Shanghai Cell Bank. The above cells were cultured at 37 °C under a humidified 95%:5% (v/v) mixture of air and CO2.
MTT assays were performed as previously described [15]. Briefly, cells were seeded into 96-well plates at a density of 5 × 103 cells/well, incubated for 12 h, and then exposed to different test compounds at different concentrations for 48 h. Next, the cells were stained with 20 μL of MTT solution (5 mg/mL) for 4h. Finally, the medium and MTT solution mixture was removed, and 150 μL of DMSO was added to dissolve formazan crystals. It was then shaken at low speed on a shaker for 10 min. The absorbance of each well was measured at 490 nm using a microplate reader. The cell growth curve was plotted with the time abscissa and the absorbance value as the ordinate.

4. Conclusions

In summary, the chemical study of Lemnalia bournei, a soft coral collected from the South China Sea, resulted in the identification of five novel biflorane-type diterpenoids, biofloranates E-I, two new bicyclic diterpene glycosides, lemnaboursides H-I, and the known lemnabourside. The structures of these compounds were elucidated using NMR spectroscopy and ECD analysis and corroborated existing literature. These compounds demonstrated antibacterial properties against Staphylococcus aureus and Bacillus subtilis, with MICs ranging from 4 to 64 µg/mL. The discovery of these compounds contributes to the diversity and complexity of terpenoids isolated from marine soft corals.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/md22040157/s1, Figures S1–S86: HRESIMS, IR, 1D and 2D NMR spectra of all new compounds 17.

Author Contributions

X.H., H.W. and B.L. performed the isolation and structure determination of the compounds and wrote the manuscript. H.O. and X.Y. performed the cytotoxic, anti-inflammatory, and antimicrobial bioassays. T.L., W.L. and S.H. collected the soft coral by SCUBA. X.C. performed the ECD calculations. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Fujian Provincial Key Laboratory of Innovative Drug Target Research (FJ-YW-2022KF01), the Ningbo Key Science and Technology Development Program (2021Z046), the National 111 Project of China (D16013), and the Li Dak Sum Yip Yio Chin Kenneth Li Marine Biopharmaceutical Development Fund of Ningbo University.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

The original data presented in the study are included in the article/Supplementary Materials; further inquiries can be directed to the corresponding author.

Acknowledgments

We thank Zhenhua Long, Daning Li, and Da Huo of the Xisha Marine Science Comprehensive Experimental Station, South China Sea Institute of Oceanology, Chinese Academy of Sciences for their assistance. We thank Xisha Marine Environment National Observation and Research Station. We would also like to thank the MS Center of the Institute of Drug Discovery Technology, Ningbo University.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Cheng, S.-Y.; Lin, E.-H.; Huang, J.-S.; Wen, Z.-H.; Duh, C.-Y. Ylangene-type and nardosinane-type sesquiterpenoids from the soft corals Lemnalia flava and Paralemnalia thyrsoides. Chem. Pharm. Bull. 2010, 58, 381–385. [Google Scholar] [CrossRef] [PubMed]
  2. Wu, Q.; Sun, J.; Chen, J.; Zhang, H.; Guo, Y.-W.; Wang, H. Terpenoids from Marine Soft Coral of the Genus Lemnalia: Chemistry and Biological Activities. Mar. Drugs 2018, 16, 320. [Google Scholar] [CrossRef] [PubMed]
  3. Wang, Q.; Tang, X.; Liu, H.; Luo, X.; Sung, P.-J.; Li, P.; Li, G. Clavukoellians G-K, New Nardosinane and Aristolane Sesquiterpenoids with Angiogenesis Promoting Activity from the Marine Soft Coral Lemnalia sp. Mar. Drugs. 2020, 18, 171. [Google Scholar] [CrossRef] [PubMed]
  4. Liu, M.; Li, P.; Tang, X.; Luo, X.; Liu, K.; Zhang, Y.; Wang, Q.; Li, G. Lemnardosinanes A-I: New Bioactive Sesquiterpenoids from Soft Coral Lemnalia sp. J. Org. Chem. 2021, 86, 970–979. [Google Scholar] [CrossRef] [PubMed]
  5. Yan, X.; Liu, J.; Li, T.; Yan, X.; He, S.; Ouyang, H.; Wang, W.; Wu, B. Antimicrobial Terpenoids from South China Sea Soft Coral Lemnalia sp. Mar. Drugs 2021, 19, 294. [Google Scholar] [CrossRef] [PubMed]
  6. Bishara, A.; Yeffet, D.; Sisso, M.; Shmul, G.; Schleyer, M.; Benayahu, Y.; Rudi, A.; Kashman, Y. Nardosinanols A-I and Lemnafricanol, Sesquiterpenes from Several Soft Corals, Lemnalia sp., Paralemnalia clavata, Lemnalia africana, and Rhytisma fulvum fulvum. J. Nat. Prod. 2008, 71, 375–380. [Google Scholar] [CrossRef] [PubMed]
  7. Su, J.-H.; Lu, Y.; Hung, W.-Y.; Huang, C.-Y.; Chiang, M.Y.; Sung, P.-J.; Kuo, Y.-H.; Sheu, J.-H. Sesquiterpenoids from the Formosan soft coral Lemnalia flava. Chem. Pharm. Bull. 2011, 59, 698–702. [Google Scholar] [CrossRef] [PubMed]
  8. Liu, M.; Li, P.; Luo, X.; Li, G.; Liu, M.; Li, P.; Luo, X.; Li, G.; van Ofwegen, L.; Tang, X. Sesquiterpenoids from the soft coral Lemnalia sp. Nat. Prod. Res. 2021, 35, 3752–3756. [Google Scholar] [CrossRef] [PubMed]
  9. Zhang, M.; Long, K.; Wu, H.; Ma, K. A novel diterpene glycoside from the soft coral of Lemnalia bournei. J. Nat. Prod. 1994, 57, 155–160. [Google Scholar] [CrossRef]
  10. Zhang, M.; Huang, Z. Two new diterpene glycosides from the soft coral Lemnalia bournei. J. Nat. Prod. 1998, 61, 1300–1301. [Google Scholar] [CrossRef] [PubMed]
  11. Zhang, B.-Y.; Huang, Z.-Y.; Li, H.; Qiu, G. A novel diterpene glycoside from the soft coral Lemnalia bournei. Tianran Chanwu Yanjiu Yu Kaifa. 2003, 15, 487–489. [Google Scholar] [CrossRef]
  12. Yan, X.; Ouyang, H.; Li, T.; Shi, Y.; Wu, B.; Yan, X.; He, S. Six new diterpene glycosides from the soft coral Lemnalia bournei. Mar. Drugs. 2021, 19, 339. [Google Scholar] [CrossRef] [PubMed]
  13. Liu, J.; Xia, F.; Ouyang, H.; Wang, W.; Li, T.; Shi, Y.; Yan, X.; Yan, X.; He, S. Nardosinane-related antimicrobial terpenoids from Lemnalia sp. soft coral. Phytochemistry 2022, 196, 113088. [Google Scholar] [CrossRef] [PubMed]
  14. Shi, Y.; Pan, C.; Auckloo, B.N.; Chen, X.; Chen, C.-T.A.; Wang, K.; Wu, X.; Ye, Y.; Wu, B. Stress-driven discovery of a cryptic antibiotic produced by Streptomyces sp. WU20 from Kueishantao hydrothermal vent with an integrated metabolomics strategy. Appl. Microbiol. Biot. 2017, 101, 1395–1408. [Google Scholar] [CrossRef] [PubMed]
  15. Zhang, N.; Chen, Y.; Jiang, R.; Li, E.; Chen, X.; Xi, Z.; Guo, Y.; Liu, X.; Zhou, Y.; Che, Y. PARP and RIP 1 are required for autophagy induced by 11′-deoxyverticillin A, which precedes caspase-dependent apoptosis. Autophagy 2011, 7, 598–612. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Chemical structures of compounds 18.
Figure 1. Chemical structures of compounds 18.
Marinedrugs 22 00157 g001
Figure 2. 1H-1H COSY and key HMBC correlations of compounds 17.
Figure 2. 1H-1H COSY and key HMBC correlations of compounds 17.
Marinedrugs 22 00157 g002
Figure 3. Key NOE correlations of compounds 17.
Figure 3. Key NOE correlations of compounds 17.
Marinedrugs 22 00157 g003
Figure 4. (a) Experimental ECD spectra of compounds 13 and 5 and calculated ECD spectrum of compound 1. (b) Experimental and calculated ECD spectra of compound 4. (c) Experimental ECD spectra of compounds 68.
Figure 4. (a) Experimental ECD spectra of compounds 13 and 5 and calculated ECD spectrum of compound 1. (b) Experimental and calculated ECD spectra of compound 4. (c) Experimental ECD spectra of compounds 68.
Marinedrugs 22 00157 g004
Table 1. 1H NMR and 13CNMR data for compounds 1 to 5 at 600 MHz in CDCl3.
Table 1. 1H NMR and 13CNMR data for compounds 1 to 5 at 600 MHz in CDCl3.
No.12345
δH (J in Hz)13CδH (J in Hz)13CδH (J in Hz)13CδH (J in Hz)13CδH (J in Hz)13C
11.58, m *21.1, CH21.91, m *18.6, CH21.89, m *18.6, CH21.25, m *22.8, CH21.52, m *18.6, CH2
1.52, m * 1.54, m * 2.01, m * 1.90, m *
21.54, m *31.4, CH21.98, m *31.3, CH21.99, m *31.3, CH21.97, m31.1, CH21.98, m *31.3, CH2
1.99, m * 1.28, m
3 133.7, C 135.0, C 134.6, C 135.4, C 134.7, C
45.54, m124.8, CH5.47, dq (5.0, 1.6)124.1, CH5.49, m124.5, CH5.44, s122.1, CH5.47, td (3.4, 1.5)124.3, CH
52.30, m34.3, CH2.05, m *36.5, CH2.02, m *36.6, CH1.76, m *39.7, CH2.04, m *36.5, CH
61.31, m *42.5, CH1.40, m *42.4, CH1.34, m *42.8, CH1.14, m *45.0, CH1.38, m42.4, CH
71.37, m *19.8, CH21.42, m *21.9, CH21.09, dd (13.0, 4.2)21.9, CH21.53, dt (9.9, 3.5)22.3, CH21.12, td (13.0, 4.2)21.9, CH2
1.29, m * 1.15, m * 1.40, dq (13.1, 4.7) 2.00, m * 1.42, m *
81.53, m * 34.8, CH21.53, m * 35.3, CH21.52, m *35.6, CH21.80, m *42.3, CH21.53, m *35.4, CH2
1.42, m 1.42, m * 1.43, dt (9.8, 3.8)
9 72.5, C 72.5, C 72.6, C 72.5, C 72.6, C
101.54, m *46.3, CH1.60, m45.7, CH21.59, m *45.8, CH1.22, d (10.4)50.2, CH1.61, dt (4.0,1.7)45.7, CH
111.74, dq (6.8, 2.8)32.0, CH1.80, dd (10.4, 5.7)31.6, CH1.71, dq (6.9, 2.9)31.7, CH2.00, m *31.3, CH1.77, dq (6.9, 2.7)31.6, CH
121.20, s36.2, CH21.54, m * 34.5, CH21.18, m *36.0, CH21.38, q (7.7)34.6, CH21.35, m34.6, CH2
1.41, m *
131.37, m25.3, CH22.37, m * 27.5, CH21.17, m *25.7, CH22.17, m *27.1, CH22.18, m27.1, CH2
2.30, m * 2.11, m
141.37, m 33.6, CH6.46, tq (7.4, 1.4)155.2, CH1.53, m * 34.3, CH26.76, tq (7.5, 1.7)142.8, CH6.73, tq (7.5, 1.4)142.9, CH
1.08, m * 1.36, m *
151.61, m *35.9, CH 139.3, C2.43, d (7.0)39.6, CH 127.5, C 127.4, C
163.50, dd, (10.4, 5.7)68.6, CH229.38, s195.5, CH 177.5, C 168.9, C 168.9, C
3.41, dd (10.5, 6.5)
170.91, d (6.7)16.8, CH31.73, s9.3, CH31.13, d (7.0)17.3, CH31.83, s12.5, CH31.82, s12.5, CH3
180.83, d (6.9)13.6, CH30.85, d (6.9)13.4, CH30.78, d (6.9)13.4, CH30.79, d (6.9)13.4, CH30.83, d (6.9)13.4, CH3
191.65, s23.8, CH31.64, s23.8, CH31.66, t (1.1)23.8, CH31.67, s24.0, CH1.64, s23.7, CH3
201.20, s29.5, CH31.30, s28.1, CH31.29, s28.1, CH31.10, s20.9, CH31.29, s28.1, CH3
21 3.67, s51.6, CH33.72, s51.8, CH33.72, s51.8, CH3
* Overlapped.
Table 2. 1H NMR and 13CNMR data for compounds 6 and 7 at 600 MHz in CDCl3.
Table 2. 1H NMR and 13CNMR data for compounds 6 and 7 at 600 MHz in CDCl3.
No.67
δH (J in Hz)13CδH (J in Hz)13C
11.84, dd * 24.8, CH21.35, m24.8, CH2
1.20, m 1.73, m
21.97, m 31.0, CH21.97, dd (12.2, 3.7)31.0, CH2
1.92, m 1.93, m
3 134. 6, C 134.7, C
45.48, m124.0, CH5.48, d (4.8)124.0, CH
52.03, m36.5, CH2.04, d (6.4)36.5, CH
61.49, m *39.1, CH1.49, m *39.2, CH
71.84, dd * 24.8, CH21.84, m *24.8, CH2
1.20, m 1.77, m
85.45, m121.6, CH5.40, d (4.7)121.6, CH
9 136.8, C 136. 8, C
101.92, m39.7, CH1.93, dd (12.2, 3.7)39.7, CH
111.77, m31.9, CH1.77, q (8.4, 6.1)32.0, CH
121.21, m36.0, CH21.18, m 36.1, CH2
1.14, m 1.14, m
131.77, m 25.3, CH21.77, m 25.1, CH2
1.36, m 1.19, m
141.47, m *
1.10, m
31.9, CH21.34, m *
1.05, q (9.0)
33.8, CH2
151.70, m *38.1, CH1.69, q (8.4, 6.1)33.3, CH
1.14, m
164.59, d (4.7)102.0, CH3.65, td (9.2, 5.5)75.6, CH2
3.29, dd (9.5, 6.2)
171.69, m *24.1, CH31.69, q (3.5)24.1, CH3
181.68, m *21.9, CH31.67, m21.9, CH3
190.81, d, (6.7)13.5, CH30.80, d (6.8)13.5, CH3
200.92, d (6.8)14.4, CH30.86, t (7.5)16.8, CH3
1′4.87, br.s98.6, CH4.46, d (8.0)101.2, CH
2′4.89, d (5.9)75.8, CH4.99, dd (9.6, 8.0)71.5, CH
3′5.15, dd (10.9, 5.9)75.4, CH5.20, t (9.5)73.0, CH
4′4.41, dd (10.9, 7.8)65.0, CH5.09, t (9.7)68.7, CH
5′3.93, dt (7.8, 1.7)80.2, CH3.67, td (9.2, 5.5)71.9, CH
6′3.96, dd (12.6, 1.3)67.7, CH24.26, dd (12.2, 4.7)62.1, CH2
3.56, dd (12.6, 2.0) 4.13, dd (12.3, 2.5)
2′-OAc2.09, s170.4, C
21.1, CH3
2.02, d (6.4)169.4, C
20.8, CH3
2.09, s21.1, CH32.02, d (6.4)20.8, CH3
3′-OAc
3′-OAc
2.12, s171.5, C
21.2, CH3
2.01, s170.5, C
20.8, CH3
2.12, s21.2, CH32.01, s20.8, CH3
4′-OAc 169.6, C
2.03, s20.8, CH3
6′-OAc 170.9, C
2.08, s20.9, CH3
* Overlapped.
Table 3. Antimicrobial activity of compounds 18.
Table 3. Antimicrobial activity of compounds 18.
CompoundsMIC (Against
Staphylococcus
aureus, µg/mL)
MIC (Against
Bacillus subtilis, µg/mL)
MIC (Against
Vibrio harveyi, µg/mL)
MIC (Against
Streptococcus pneumoniae, µg/mL)
MIC (Against
Escherichia coli,
µg/mL)
1323264>128>128
2323264>128128
36432>128>128>128
46464>128>128>128
56432>128>128>128
6161632>1288
7321664>12832
88432>1288
Penicillin a<0.5<0.5<0.58<0.5
a Positive control.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Han, X.; Wang, H.; Li, B.; Chen, X.; Li, T.; Yan, X.; Ouyang, H.; Lin, W.; He, S. New Diterpenes and Diterpene Glycosides with Antibacterial Activity from Soft Coral Lemnalia bournei. Mar. Drugs 2024, 22, 157. https://doi.org/10.3390/md22040157

AMA Style

Han X, Wang H, Li B, Chen X, Li T, Yan X, Ouyang H, Lin W, He S. New Diterpenes and Diterpene Glycosides with Antibacterial Activity from Soft Coral Lemnalia bournei. Marine Drugs. 2024; 22(4):157. https://doi.org/10.3390/md22040157

Chicago/Turabian Style

Han, Xiao, Huiting Wang, Bing Li, Xiaoyi Chen, Te Li, Xia Yan, Han Ouyang, Wenhan Lin, and Shan He. 2024. "New Diterpenes and Diterpene Glycosides with Antibacterial Activity from Soft Coral Lemnalia bournei" Marine Drugs 22, no. 4: 157. https://doi.org/10.3390/md22040157

APA Style

Han, X., Wang, H., Li, B., Chen, X., Li, T., Yan, X., Ouyang, H., Lin, W., & He, S. (2024). New Diterpenes and Diterpene Glycosides with Antibacterial Activity from Soft Coral Lemnalia bournei. Marine Drugs, 22(4), 157. https://doi.org/10.3390/md22040157

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop